We compared mouse embryonic expression of the MDM2 proto-oncogene, p21
MDM2 regulates cell growth and differentiation through effects on tumour suppressors such as p53 and pRb (reviews: Haines, 1997; Momand and Zambetti, 1997; Piette et al., 1997) . p53 regulates development, cell-cycle progression and apoptosis in response to cellular stress and teratogens (reviews: Hall and Lane, 1997; Hansen and Oren, 1997; Levine, 1997) . p53 null mice have: a high tumour incidence, developmental defects in the neural tube and spermatogenesis (reviews: Almog and Rotter, 1997; Hall and Lane, 1997) , and birth defects (Nicol et al., 1995; Norimura et al., 1996) . p53 protein levels are regulated positively by hypoxia-inducible factor 1a and negatively by MDM2 (Haupt et al., 1997; Kubbutat et al., 1997; Midgley and Lane, 1997) . Inhibition of p53 by MDM2 is neutralised by the ARF-INK4a tumour suppressor (Pomerantz et al., 1998; Zhang et al., 1998) . Although p53 downregulation by MDM2 is critical for early embryonal development (Jones et al., 1995; Montes de Oca Luna et al., 1995) , there are p53-independent effects of MDM2. MDM2 over-expression is associated with tumourigenesis, reflecting its effects on cell growth and differentiation. We compared MDM2, p53 and p21 WAF1/CIP1 expression during mouse embryogenesis by in situ hybridisation on serial cryosections (Table 1) .
MDM2 is ubiquitously expressed at early stages (Montes de Oca Luna et al., 1996) . At 7.5 dpc, there is a low expression in the three germ layers of the embryo that was also detected by Northern blotting, and high expression in two circular zones in the maternal endometrial decidua but not in the uterine wall. At 10.5 and 11.5 dpc, embryonal expression is low and ubiquitous. At 12.5 dpc, expression becomes (b) and MDM2 (c) RNA expression at 14.5 dpc. Dark field views of adjacent sagittal sections. b, bronchi; c, neuro-epithelium of the cerebral cortex; d, diaphragm; h, heart; i, incisor; k, kidney; li, liver; lu, lung; mo, molars; mu, muscle; ns, nasal sinus; sg, salivary gland; to, tongue; ts, testis.
Fig. 2. Expression in adjacent sagittal sections of p21
WAF1/CIP1 (b) and MDM2 (c) in the nasal cavity at 14.5 dpc and of p53 (e), p21 WAF1/CIP1 (g) and MDM2 (i) in the lower incisor at 18.5 dpc. Bright-and dark-field pairs: (a,b), (d,e), (f,g), (h,i). am, ameloblast layer; to, tongue; i, incisor; m, molars; op, oropharynx; nc, nasal cavity; np, nasopharynx; od, odontoblast layer. more restricted, with high levels in the primitive sex cords, the precursors of seminiferous tubules. MDM2 is a marker of testes, which are morphologically indistinguishable from female gonads until 13.5 dpc. Testicular expression is high at 14.5 (Fig. 1c) and 18.5 dpc. At 14.5 dpc, MDM2 is highly expressed in the airways: the nasal cavity (Figs. 1c and 2c) , the nasopharynx, larynx, bronchi, and oesophagus. There is a precise loss of expression from respiratory to olfactory epithelium (Fig. 2c) . At 18.5 dpc, expression is detected in the respiratory epithelia of the pharyngo-tympanic (Eustachian) tube and the nasopharynx, as well as the inner and outer (neuroblastic) layers of the retina and in the lens of the eye. Interestingly, MDM2 regulates pRb, a tumour suppressor implicated in eye development (Howes et al., 1994) . MDM2 is expressed in the tooth, at 14.5 dpc in the upper incisor (Fig. 1c) and at 18.5 dpc in the incisors and molars (Fig. 2h,i) .
MDM2 expression resembles p53 early in embryogenesis. They are ubiquitous at 10.5 and 11.5 dpc, and coexpressed in the neural tube at 12.5 dpc and in the neuroepithelium of the cerebral cortex at 14.5 dpc (Fig. 1a,c ; Schmid et al., 1991; Montes de Oca Luna et al., 1996) . MDM2 may generally modulate p53-dependent apoptosis during early development. MDM2 and p21 WAF1/CIP1 expression also differ from p53. At 10.5 and 11.5 dpc, p21 WAF1/CIP1 is specifically expressed in the dermomyotome of the somites (Parker et al., 1995) . At 14.5 dpc, p53 (Fig. 1a) is expressed in the liver, the lung parenchyma, the cortex of the kidney, the salivary gland and the teeth. p21 WAF1/CIP1 (Fig. 1b) is expressed in muscles, tongue, diaphragm, bronchi and nasal sinus. MDM2 (Fig.  1c) is expressed in the testes, nasal sinus and bronchi. The striking differences are: only MDM2 is highly expressed in the testes (Fig. 1a,c) , and MDM2 and p21 WAF1/CIP1 , unlike p53, are expressed in the two layers of the retina (not shown), the nasal sinuses (Fig. 1a-c) and the respiratory epithelium ( Fig. 2a-c) . At 18.5 dpc, the three genes are differentially expressed in the molars and incisors (Fig.  2d-i) . In the incisors, p53 is expressed in the proliferating posterior compartment (Fig. 2d,e) , p21 WAF1/CIP1 in differentiating anterior odontoblasts and ameloblasts (Fig. 2f,g ) and MDM2 in ameloblasts and more weakly in odontoblasts (Fig. 2h,i) . Incisor abnormalities are observed in p53 −/− embryos (Armstrong et al., 1995) . We studied the p53 dependence of MDM2 and p21 WAF1/ CIP1 expression. In p53 null 14.5 dpc embryos, in the nasal sinus, there is specific expression of p21 WAF1/CIP1 RNA ( Fig.  3e-h ) and MDM2 RNA (Fig. 3a-d ) and protein (Fig. 4a-c,e,f) . p53 null embryos with exencephaly (Armstrong et al., 1995; Sah et al., 1995) have abnormal nasal cavities but express normal levels of MDM2 and p21 WAF1/CIP1 (not shown). Fourteen-dpc embryo nose and Fig. 4 . MDM2 protein expression in the nasal cavity at 14.5 dpc. Adjacent sagittal sections probed with no primary antibodies (a) or no. 365 anti-MDM2 antibodies (c, higher magnification of (b,e,f), wild type and corresponding p53 null). (d) Western with Ab no. 365 and extracts from 3T3DM (1), 14.5-dpc nose and upper jaw (2) and adult testis (3). ee, entrance oesophagus; ep, epiglottis; la, laryngeal aditus; nc, nasal cavity; np, nasopharynx; oe, olfactory epithelium; op, oropharynx; re, respiratory epithelium; tr, trachea.
upper jaw extracts contain 90 000 MDM2 (Fig. 4d) which has the p53 binding site. However, other MDM2 isoforms may also be expressed, since the antibodies recognise Nterminal epitopes (168-183, Fig. 4, 1-177 , not shown). p53-independent tissue-specific expression of MDM2 appears to be general. MDM2 and p21 WAF1/CIP1 are expressed at similar levels in wt and p53 null foetuses: in whole embryos at 10.5 dpc (not shown), in the nasal epithelium at 14.5 dpc and in the tooth at 18.5 dpc (not shown). MDM2 expression in adult mice is p53-independent (Ibrahim et al., 1997). The p53-independent mechanisms of MDM2 regulation are of interest in understanding development, apoptosis and tumourigenesis, and they could provide a means to regulate p53 for cancer therapy.
Experimental procedures
Six-micrometer mouse embryo cryosections were analysed by 1. in situ hybridisation (Décimo et al., 1995; Niederreither and Dollé, 1998) ) and J. Jenkins (p53)) and 2. immunohistochemistry (standard protocol) with affinitypurified rabbit polyclonal antibodies (MDM2 epitopes: amino acids 168-183 (Ab 365) and 1-177 (Ab 370)) and an ABC Elite kit (Vectastain).
